Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 172

1.

Cognitive and brain reserve in multiple sclerosis--A cross-sectional study.

Ifantopoulou P, Artemiadis AK, Bakirtzis C, Zekiou K, Papadopoulos TS, Diakogiannis I, Hadjigeorgiou G, Grigoriadis N, Orologas A.

Mult Scler Relat Disord. 2019 Jul 29;35:128-134. doi: 10.1016/j.msard.2019.07.027. [Epub ahead of print]

PMID:
31374461
2.

Exercise intensity-dependent immunomodulatory effects on encephalomyelitis.

Fainstein N, Tyk R, Touloumi O, Lagoudaki R, Goldberg Y, Agranyoni O, Navon-Venezia S, Katz A, Grigoriadis N, Ben-Hur T, Einstein O.

Ann Clin Transl Neurol. 2019 Aug 1. doi: 10.1002/acn3.50859. [Epub ahead of print]

3.

TREM2 R47H (rs75932628) variant is unlikely to contribute to Multiple Sclerosis susceptibility and severity in a large Greek MS cohort.

Rikos D, Siokas V, Aloizou AM, Tsouris Z, Aslanidou P, Koutsis G, Anagnostouli M, Bogdanos DP, Grigoriadis N, Hadjigeorgiou GM, Dardiotis E.

Mult Scler Relat Disord. 2019 Jul 20;35:116-118. doi: 10.1016/j.msard.2019.07.007. [Epub ahead of print]

PMID:
31362167
4.

EEG Window Length Evaluation for the Detection of Alzheimer's Disease over Different Brain Regions.

Tzimourta KD, Giannakeas N, Tzallas AT, Astrakas LG, Afrantou T, Ioannidis P, Grigoriadis N, Angelidis P, Tsalikakis DG, Tsipouras MG.

Brain Sci. 2019 Apr 14;9(4). pii: E81. doi: 10.3390/brainsci9040081.

5.

Induction of apoptosis in CD4(+) T-cells is linked with optimal treatment response in patients with relapsing-remitting multiple sclerosis treated with Glatiramer acetate.

Boziki M, Lagoudaki R, Melo P, Kanidou F, Bakirtzis C, Nikolaidis I, Grigoriadou E, Afrantou T, Tatsi T, Matsi S, Grigoriadis N.

J Neurol Sci. 2019 Jun 15;401:43-50. doi: 10.1016/j.jns.2019.03.030. Epub 2019 Mar 29.

PMID:
31009931
6.

Microbes and Alzheimer' disease: lessons from H. pylori and GUT microbiota.

Doulberis M, Papaefthymiou A, Polyzos SA, Boziki M, Deretzi G, Giartza-Taxidou E, Vardaka E, Grigoriadis N, Katsinelos T, Touloumtzi M, Papanikopoulou K, Anastasiadou K, Georgopoulos S, Dardiotis E, Anastasiadis S, Katsinelos P, Kountouras J.

Eur Rev Med Pharmacol Sci. 2019 Mar;23(5):1845-1846. doi: 10.26355/eurrev_201903_17218. No abstract available.

PMID:
30915725
Free Article
7.

Comment on: "Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis".

Tsivgoulis G, Palaiodimou L, Katsanos AH, Voumvourakis K, Hadjigeorgiou GM, Heliopoulos I, Karapanayiotides T, Papathanasopoulos P, Kilidireas C, Grigoriadis N.

CNS Drugs. 2019 Mar;33(3):293-295. doi: 10.1007/s40263-019-00615-5. No abstract available.

PMID:
30806966
8.

Helicobacter pylori infection and gastric cancer biology: tempering a double-edged sword.

Mentis AA, Boziki M, Grigoriadis N, Papavassiliou AG.

Cell Mol Life Sci. 2019 Jul;76(13):2477-2486. doi: 10.1007/s00018-019-03044-1. Epub 2019 Feb 19.

PMID:
30783683
9.

Gene variants of adhesion molecules predispose to MS: A case-control study.

Dardiotis E, Panayiotou E, Siokas V, Aloizou AM, Christodoulou K, Hadjisavvas A, Pantzaris M, Grigoriadis N, Hadjigeorgiou GM, Kyriakides T.

Neurol Genet. 2019 Jan 16;5(1):e304. doi: 10.1212/NXG.0000000000000304. eCollection 2019 Feb.

10.

The autism/neuroprotection-linked ADNP/NAP regulate the excitatory glutamatergic synapse.

Sragovich S, Malishkevich A, Piontkewitz Y, Giladi E, Touloumi O, Lagoudaki R, Grigoriadis N, Gozes I.

Transl Psychiatry. 2019 Jan 15;9(1):2. doi: 10.1038/s41398-018-0357-6.

11.

Atypical Auditory Brainstem Response and Protein Expression Aberrations Related to ASD and Hearing Loss in the Adnp Haploinsufficient Mouse Brain.

Hacohen-Kleiman G, Yizhar-Barnea O, Touloumi O, Lagoudaki R, Avraham KB, Grigoriadis N, Gozes I.

Neurochem Res. 2019 Jun;44(6):1494-1507. doi: 10.1007/s11064-019-02723-6. Epub 2019 Jan 18.

PMID:
30659505
12.

Can We Design a Nogo Receptor-Dependent Cellular Therapy to Target MS?

Kim MJ, Kang JH, Theotokis P, Grigoriadis N, Petratos S.

Cells. 2018 Dec 20;8(1). pii: E1. doi: 10.3390/cells8010001. Review.

13.

Replication study of GWAS risk loci in Greek multiple sclerosis patients.

Hadjigeorgiou GM, Kountra PM, Koutsis G, Tsimourtou V, Siokas V, Dardioti M, Rikos D, Marogianni C, Aloizou AM, Karadima G, Ralli S, Grigoriadis N, Bogdanos D, Panas M, Dardiotis E.

Neurol Sci. 2019 Feb;40(2):253-260. doi: 10.1007/s10072-018-3617-6. Epub 2018 Oct 26.

PMID:
30361804
14.

Estimating Everyday Neuropsychological Functioning in Multiple Sclerosis: Reliability and Validity of the Greek Multiple Sclerosis Neuropsychological Questionnaire.

Konstantinopoulou E, Ioannidis P, Bakirtzis C, Giantzi V, Afrantou T, Parissis D, Messinis L, Nasios G, Grigoriadis N.

Mult Scler Int. 2018 Sep 25;2018:6301535. doi: 10.1155/2018/6301535. eCollection 2018.

15.

Long-term effects of prolonged-release fampridine in cognitive function, fatigue, mood and quality of life of MS patients: The IGNITE study.

Bakirtzis C, Konstantinopoulou E, Langdon DW, Grigoriadou E, Minti F, Nikolaidis I, Boziki MK, Tatsi T, Ioannidis P, Karapanayiotides T, Afrantou T, Hadjigeorgiou G, Grigoriadis N.

J Neurol Sci. 2018 Dec 15;395:106-112. doi: 10.1016/j.jns.2018.10.004. Epub 2018 Oct 4.

PMID:
30308444
16.

Uncovering the pharmacological response of novel sesquiterpene derivatives that differentially alter gene expression and modulate the cell cycle in cancer cells.

Akrivou MG, Demertzidou VP, Theodoroula NF, Chatzopoulou FM, Kyritsis KA, Grigoriadis N, Zografos AL, Vizirianakis IS.

Int J Oncol. 2018 Nov;53(5):2167-2179. doi: 10.3892/ijo.2018.4550. Epub 2018 Sep 3.

PMID:
30226586
17.

The Rationale for Monitoring Cognitive Function in Multiple Sclerosis: Practical Issues for Clinicians.

Bakirtzis C, Ioannidis P, Messinis L, Nasios G, Konstantinopoulou E, Papathanasopoulos P, Grigoriadis N.

Open Neurol J. 2018 May 31;12:31-40. doi: 10.2174/1874205X01812010031. eCollection 2018. Review.

18.

White matter hyperintensities in myotonic dystrophy type 2: Not always another expression of the disease.

Karatzikou M, Bakirtzis C, Nikolaidis J, Parisis D, Grigoriadis N.

Mult Scler Relat Disord. 2018 Aug;24:117-119. doi: 10.1016/j.msard.2018.06.020. Epub 2018 Jun 30.

PMID:
29982108
19.

Reliability and validity of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis (Greek version) and proposed modification.

Printza A, Kalaitzi M, Bakirtzis C, Nikolaidis I, Proios H, Grigoriadis N.

Mult Scler Relat Disord. 2018 Jul;23:62-68. doi: 10.1016/j.msard.2018.05.004. Epub 2018 May 10.

PMID:
29778042
20.

Commentary on: Comparing the efficacy of disease-modifying therapies in multiple sclerosis.

Tsivgoulis G, Katsanos AH, Voumvourakis K, Hadjigeorgiou GM, Heliopoulos I, Karapanayiotides T, Papathanasopoulos P, Kilidireas C, Grigoriadis N.

Mult Scler Relat Disord. 2018 Apr;21:117-119. doi: 10.1016/j.msard.2018.03.010. Epub 2018 Mar 15. No abstract available.

PMID:
29724375
21.

Cyclization of PLP139-151 peptide reduces its encephalitogenic potential in experimental autoimmune encephalomyelitis.

Lourbopoulos A, Matsoukas MT, Katsara M, Deraos G, Giannakopoulou A, Lagoudaki R, Grigoriadis N, Matsoukas J, Apostolopoulos V.

Bioorg Med Chem. 2018 May 15;26(9):2221-2228. doi: 10.1016/j.bmc.2017.12.024. Epub 2017 Dec 19.

PMID:
29681483
22.

Efficacy of a Computer-Assisted Cognitive Rehabilitation Intervention in Relapsing-Remitting Multiple Sclerosis Patients: A Multicenter Randomized Controlled Trial.

Messinis L, Nasios G, Kosmidis MH, Zampakis P, Malefaki S, Ntoskou K, Nousia A, Bakirtzis C, Grigoriadis N, Gourzis P, Papathanasopoulos P.

Behav Neurol. 2017;2017:5919841. doi: 10.1155/2017/5919841. Epub 2017 Dec 31.

23.

p75NTR and TROY: Uncharted Roles of Nogo Receptor Complex in Experimental Autoimmune Encephalomyelitis.

Theotokis P, Grigoriadis N.

Mol Neurobiol. 2018 Aug;55(8):6329-6336. doi: 10.1007/s12035-017-0841-7. Epub 2018 Jan 2. Review.

PMID:
29294247
24.

A potential impact of Helicobacter pylori-related galectin-3 in neurodegeneration.

Boziki M, Polyzos SA, Deretzi G, Kazakos E, Katsinelos P, Doulberis M, Kotronis G, Giartza-Taxidou E, Laskaridis L, Tzivras D, Vardaka E, Kountouras C, Grigoriadis N, Thomann R, Kountouras J.

Neurochem Int. 2018 Feb;113:137-151. doi: 10.1016/j.neuint.2017.12.003. Epub 2017 Dec 13. Review.

PMID:
29246761
25.

Humoral response in experimental autoimmune encephalomyelitis targets neural precursor cells in the central nervous system of naive rodents.

Kesidou E, Touloumi O, Lagoudaki R, Nousiopoulou E, Theotokis P, Poulatsidou KN, Boziki M, Kofidou E, Delivanoglou N, Minti F, Hadjigeorgiou G, Grigoriadis N, Simeonidou C.

J Neuroinflammation. 2017 Nov 21;14(1):227. doi: 10.1186/s12974-017-0995-2.

26.

Exercise training attenuates experimental autoimmune encephalomyelitis by peripheral immunomodulation rather than direct neuroprotection.

Einstein O, Fainstein N, Touloumi O, Lagoudaki R, Hanya E, Grigoriadis N, Katz A, Ben-Hur T.

Exp Neurol. 2018 Jan;299(Pt A):56-64. doi: 10.1016/j.expneurol.2017.10.008. Epub 2017 Oct 12.

PMID:
29031957
27.

An Update on the Role of Matrix Metalloproteinases in the Pathogenesis of Multiple Sclerosis.

Boziki M, Grigoriadis N.

Med Chem. 2018 Feb 6;14(2):155-169. doi: 10.2174/1573406413666170906122803. Review.

PMID:
28875862
28.

Cyclic MOG35-55 ameliorates clinical and neuropathological features of experimental autoimmune encephalomyelitis.

Lourbopoulos A, Deraos G, Matsoukas MT, Touloumi O, Giannakopoulou A, Kalbacher H, Grigoriadis N, Apostolopoulos V, Matsoukas J.

Bioorg Med Chem. 2017 Aug 1;25(15):4163-4174. doi: 10.1016/j.bmc.2017.06.005. Epub 2017 Jun 7.

PMID:
28642030
29.

Viruses and endogenous retroviruses in multiple sclerosis: From correlation to causation.

Mentis AA, Dardiotis E, Grigoriadis N, Petinaki E, Hadjigeorgiou GM.

Acta Neurol Scand. 2017 Dec;136(6):606-616. doi: 10.1111/ane.12775. Epub 2017 May 23. Review.

PMID:
28542724
30.

Gene variants of adhesion molecules act as modifiers of disease severity in MS.

Dardiotis E, Panayiotou E, Provatas A, Christodoulou K, Hadjisavvas A, Antoniades A, Lourbopoulos A, Pantzaris M, Grigoriadis N, Hadjigeorgiou GM, Kyriakides T.

Neurol Neuroimmunol Neuroinflamm. 2017 Apr 24;4(4):e350. doi: 10.1212/NXI.0000000000000350. eCollection 2017 Jul.

31.

Viruses and Multiple Sclerosis: From Mechanisms and Pathways to Translational Research Opportunities.

Mentis AA, Dardiotis E, Grigoriadis N, Petinaki E, Hadjigeorgiou GM.

Mol Neurobiol. 2017 Jul;54(5):3911-3923. doi: 10.1007/s12035-017-0530-6. Epub 2017 Apr 28. Review.

PMID:
28455696
32.

A case of CD30+ ALK1- anaplastic large cell lymphoma resembling acute disseminated encephalomyelitis.

Afrantou T, Natsis KS, Papadopoulos G, Lagoudaki R, Poulios C, Mamouli D, Kostopoulos I, Grigoriadis N.

Mult Scler Relat Disord. 2017 Apr;13:119-121. doi: 10.1016/j.msard.2017.03.003. Epub 2017 Mar 6.

PMID:
28427693
33.

Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus Risks.

Alroughani R, Altintas A, Al Jumah M, Sahraian M, Alsharoqi I, AlTahan A, Daif A, Dahdaleh M, Deleu D, Fernandez O, Grigoriadis N, Inshasi J, Karabudak R, Taha K, Totolyan N, Yamout BI, Zakaria M, Bohlega S.

Mult Scler Int. 2016;2016:1034912. doi: 10.1155/2016/1034912. Epub 2016 Dec 18. Review.

34.

Helicobacter pylori eradication to prevent cardio-cerebrovascular disease: Are current data useful for clinical practice?

Kountouras J, Polyzos SA, Katsinelos P, Zeglinas C, Artemaki F, Tzivras D, Vardaka E, Gavalas E, Romiopoulos I, Simeonidou C, Grigoriadis N, Kountouras C, Dardiotis E, Deretzi G.

Int J Cardiol. 2017 Apr 15;233:92. doi: 10.1016/j.ijcard.2016.12.152. Epub 2016 Dec 23. No abstract available.

PMID:
28043671
35.

Platelet-rich plasma in otolaryngology.

Stavrakas M, Karkos PD, Markou K, Grigoriadis N.

J Laryngol Otol. 2016 Dec;130(12):1098-1102. Review.

PMID:
27938467
36.

CADASIL presenting with spontaneous intracerebral hemorrhage: report of a case and description of the first family in Northern Greece.

Koutroulou I, Karapanayiotides T, Grigoriadis N, Karacostas D.

Hippokratia. 2016 Jan-Mar;20(1):76-79.

37.

Cardio-cerebrovascular disease and Helicobacter pylori-related metabolic syndrome: We consider eradication therapy as a potential cardio-cerebrovascular prevention strategy.

Kountouras J, Polyzos SA, Katsinelos P, Zeglinas C, Artemaki F, Tzivras D, Vardaka E, Gavalas E, Romiopoulos I, Simeonidou C, Grigoriadis N, Kountouras C, Dardiotis E, Deretzi G.

Int J Cardiol. 2017 Feb 15;229:17-18. doi: 10.1016/j.ijcard.2016.11.265. Epub 2016 Nov 19. No abstract available.

PMID:
27887801
38.

Long-term effects of autoimmune CNS inflammation on adult hippocampal neurogenesis.

Giannakopoulou A, Lyras GA, Grigoriadis N.

J Neurosci Res. 2017 Jul;95(7):1446-1458. doi: 10.1002/jnr.23982. Epub 2016 Oct 26.

PMID:
27781303
39.

Nogo receptor complex expression dynamics in the inflammatory foci of central nervous system experimental autoimmune demyelination.

Theotokis P, Touloumi O, Lagoudaki R, Nousiopoulou E, Kesidou E, Siafis S, Tselios T, Lourbopoulos A, Karacostas D, Grigoriadis N, Simeonidou C.

J Neuroinflammation. 2016 Oct 11;13(1):265.

40.

The Efficacy of Natalizumab versus Fingolimod for Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review, Indirect Evidence from Randomized Placebo-Controlled Trials and Meta-Analysis of Observational Head-to-Head Trials.

Tsivgoulis G, Katsanos AH, Mavridis D, Grigoriadis N, Dardiotis E, Heliopoulos I, Papathanasopoulos P, Karapanayiotides T, Kilidireas C, Hadjigeorgiou GM, Voumvourakis K; HELANI (Hellenic Academy of Neuroimmunology).

PLoS One. 2016 Sep 29;11(9):e0163296. doi: 10.1371/journal.pone.0163296. eCollection 2016.

41.

Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in Greek population with multiple sclerosis.

Polychroniadou E, Bakirtzis C, Langdon D, Lagoudaki R, Kesidou E, Theotokis P, Tsalikakis D, Poulatsidou K, Kyriazis O, Boziki M, Papadopoulos G, Boura E, Sintila L, Hatzigeorgiou S, Ziamos C, Ioannidis P, Karacostas D, Grigoriadis N.

Mult Scler Relat Disord. 2016 Sep;9:68-72. doi: 10.1016/j.msard.2016.06.011. Epub 2016 Jun 28.

PMID:
27645348
42.

Considerations on long-term immuno-intervention in the treatment of multiple sclerosis: an expert opinion.

Grigoriadis N, Linnebank M, Alexandri N, Muehl S, Hofbauer GF.

Expert Opin Pharmacother. 2016 Oct;17(15):2085-95. doi: 10.1080/14656566.2016.1232712. Epub 2016 Sep 15. Review.

PMID:
27594523
43.

Telmisartan-mediated metabolic profile conferred brain protection in diabetic hypertensive rats as evidenced by magnetic resonance imaging, behavioral studies and histology.

Younis FM, Blumenthal-Katzir T, Hollander K, Grigoriadis N, Touloumi O, Lagoudakic R, Rosenthal T.

Eur J Pharmacol. 2016 Oct 15;789:88-97. doi: 10.1016/j.ejphar.2016.07.021. Epub 2016 Jul 12.

PMID:
27417654
44.

Pharmacological preconditioning for short-term ex vivo expansion of human umbilical cord blood hematopoietic stem cells by filgrastim.

Grigoriadis NG, Grigoriadis IG, Markoula S, Paschopoulos M, Zikopoulos K, Apostolakopoulos PG, Vizirianakis IS, Georgiou I.

Am J Stem Cells. 2016 May 15;5(1):29-38. eCollection 2016.

45.

Correction: Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.

Mouzaki A, Rodi M, Dimisianos N, Emmanuil A, Kalavrizioti D, Lagoudaki R, Grigoriadis NC, Papathanasopoulos P.

PLoS One. 2016 Mar 10;11(3):e0151411. doi: 10.1371/journal.pone.0151411. eCollection 2016. No abstract available.

46.

The Impact of Methylprednisolone Pulses during Relapses of Multiple Sclerosis on the Kinetics of Anti-Interferon-Beta Antibodies.

Giantzi V, Karapanayiotides T, Lagoudaki R, Poulatsidou KN, Lourbopoulos A, Daniilidis M, Taskos N, Milonas I, Grigoriadis N.

Eur Neurol. 2016;75(1-2):82-8. doi: 10.1159/000444319. Epub 2016 Feb 12.

PMID:
26867030
47.

Sexual divergence in microtubule function: the novel intranasal microtubule targeting SKIP normalizes axonal transport and enhances memory.

Amram N, Hacohen-Kleiman G, Sragovich S, Malishkevich A, Katz J, Touloumi O, Lagoudaki R, Grigoriadis NC, Giladi E, Yeheskel A, Pasmanik-Chor M, Jouroukhin Y, Gozes I.

Mol Psychiatry. 2016 Oct;21(10):1467-76. doi: 10.1038/mp.2015.208. Epub 2016 Jan 19.

PMID:
26782054
48.

Helicobacter Pylori-Related Vitamin B12 Deficiency: A Potential Contributor in Neuropsychiatric Disorders.

Kountouras J, Polyzos SA, Grigoriadis N, Deretzi G.

Indian J Psychol Med. 2015 Oct-Dec;37(4):475-6. doi: 10.4103/0253-7176.168616. No abstract available.

49.

The Effect of Disease Modifying Therapies on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis.

Tsivgoulis G, Katsanos AH, Grigoriadis N, Hadjigeorgiou GM, Heliopoulos I, Papathanasopoulos P, Kilidireas C, Voumvourakis K, Dardiotis E; HELANI (Hellenic Academy of Neuroimmunology).

PLoS One. 2015 Dec 7;10(12):e0144538. doi: 10.1371/journal.pone.0144538. eCollection 2015. Review.

50.

Immunophenotype of mouse cerebral hemispheres-derived neural precursor cells.

Poulatsidou KN, Lagoudaki R, Touloumi O, Kesidou E, Boziki M, Ravanidis S, Chlichlia K, Grigoriou M, Grigoriadis N.

Neurosci Lett. 2016 Jan 12;611:33-9. doi: 10.1016/j.neulet.2015.11.011. Epub 2015 Nov 15.

PMID:
26590329

Supplemental Content

Loading ...
Support Center